Shannon L. Devers' Stock Sale Plan for Ionis Pharmaceuticals

Shannon L. Devers, an officer at Ionis Pharmaceuticals Inc, has filed a Form 144 to sell shares of the company's common stock. The filing outlines a plan adopted on September 3, 2024, to sell a total of 15,670 shares. The shares were acquired through various transactions, including option exercises and restricted stock units, with acquisition dates ranging from April 5, 2020, to January 16, 2024. The approximate sale date is set for October 15, 2025, with an aggregate market value of $1,175,250. Additionally, Devers sold 3,162 shares on September 3, 2025, generating gross proceeds of $192,882. The filing indicates that there are no other securities sold in the past three months.